Relationship between multimorbidity, demographic factors and mortality: findings from the UK Biobank cohort
Top Cited Papers
Open Access
- 10 April 2019
- journal article
- research article
- Published by Springer Science and Business Media LLC in BMC Medicine
- Vol. 17 (1), 1-13
- https://doi.org/10.1186/s12916-019-1305-x
Abstract
Multimorbidity is associated with higher mortality, but the relationship with cancer and cardiovascular mortality is unclear. The influence of demographics and type of condition on the relationship of multimorbidity with mortality remains unknown. We examine the relationship between multimorbidity (number/type) and cause of mortality and the impact of demographic factors on this relationship. Data source: the UK Biobank; 500,769 participants; 37-73 years; 53.7% female. Exposure variables: number and type of long-term conditions (LTCs) (N = 43) at baseline, modelled separately. Cox regression models were used to study the impact of LTCs on all-cause/vascular/cancer mortality during median 7-year follow-up. All-cause mortality regression models were stratified by age/sex/socioeconomic status. All-cause mortality is 2.9% (14,348 participants). Of all deaths, 8350 (58.2%) were cancer deaths and 2985 (20.8%) vascular deaths. Dose-response relationship is observed between the increasing number of LTCs and all-cause/cancer/vascular mortality. A strong association is observed between cardiometabolic multimorbidity and all three clinical outcomes; non-cardiometabolic multimorbidity (excluding cancer) is associated with all-cause/vascular mortality. All-cause mortality risk for those with ≥ 4 LTCs was nearly 3 times higher than those with no LTCs (HR 2.79, CI 2.61–2.98); for ≥ 4 cardiometabolic conditions, it was > 3 times higher (HR 3.20, CI 2.56–4.00); and for ≥ 4 non-cardiometabolic conditions (excluding cancer), it was 50% more (HR 1.50, CI 1.36–1.67). For those with ≥ 4 LTCs, morbidity combinations that included cardiometabolic conditions, chronic kidney disease, cancer, epilepsy, chronic obstructive pulmonary disease, depression, osteoporosis and connective tissue disorders had the greatest impact on all-cause mortality. In the stratified model by age/sex, absolute all-cause mortality was higher among the 60–73 age group with an increasing number of LTCs; however, the relative effect size of the increasing number of LTCs on higher mortality risk was larger among those 37–49 years, especially men. While socioeconomic status was a significant predictor of all-cause mortality, mortality risk with increasing number of LTCs remained constant across different socioeconomic gradients. Multimorbidity is associated with higher all-cause/cancer/vascular mortality. Type, as opposed to number, of LTCs may have an important role in understanding the relationship between multimorbidity and mortality. Multimorbidity had a greater relative impact on all-cause mortality in middle-aged as opposed to older populations, particularly males, which deserves exploration.Keywords
Funding Information
- Chief Scientist Office (CGA/16/39)
This publication has 34 references indexed in Scilit:
- The impact of comorbidity on cancer survival: a reviewClinical Epidemiology, 2013
- Comparing measures of multimorbidity to predict outcomes in primary care: a cross sectional studyFamily Practice, 2012
- Managing patients with multimorbidity: systematic review of interventions in primary care and community settingsBMJ, 2012
- Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional studyThe Lancet, 2012
- Comparing comorbidity measures for predicting mortality and hospitalization in three population-based cohortsBMC Health Services Research, 2011
- The impact of chronic multimorbidity and disability on functional decline and survival in elderly persons. A community‐based, longitudinal studyJournal of Internal Medicine, 2009
- The impact of comorbidity and stage on ovarian cancer mortality: A nationwide Danish cohort studyBMC Cancer, 2008
- Multiple Chronic Conditions: Prevalence, Health Consequences, and Implications for Quality, Care Management, and CostsJournal of General Internal Medicine, 2007
- The Quality of Factor Solutions in Exploratory Factor Analysis: The Influence of Sample Size, Communality, and OverdeterminationEducational and Psychological Measurement, 2005
- DeprivationJournal of Social Policy, 1987